Wanted: Participants to New Moffitt Cancer Center Lung Cancer Trial
Researchers at the H. Lee Moffitt Cancer Center & Research Institute are testing a new drug – sulindac – to evaluate its potential in reversing the smoking-related damages to the lungs in order to lower the risk of getting lung cancer.
Previous studies have shown that sulindac has been beneficial in preventing the development of pre-cancerous polyps in the colon.
Now, doctors at Moffitt would like to see of the drug will work similarly on the lung’s cells. They’ve opened a new clinical trial are looking for the following patient population:
- people between 45 and 79 years old who have smoked at least one pack of cigarettes a day for 30 years
- current and former smokers who have changes in their sputum, or cells coughed from the lungs, that demonstrate changes caused by years of smoking
- former smokers who have no history of lung cancer or those with stage 1 non-small cell lung cancer that was removed at least one year prior to the screening exam
If you think you qualify and interested in participating in the said trial, you may call Moffitt Cancer Center at (813) 745-3685.
Read the full report.
Tags: lung-cancer, lung-cancer-trial, Moffitt-Cancer-Center, sulindacRelated Stories
POSTED IN: on anti-cancer ingredients, on lung cancer
0 opinions for Wanted: Participants to New Moffitt Cancer Center Lung Cancer Trial
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: